Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist with a slightly different mechanism
Monitoring and adaptation should be ongoing throughout your treatment journey
These evidences all suggest that the action of GLP-1R in liver cells may be directly stimulated by ligand-receptor action
3.1 Biological Interpretation of GSH and GSSG Concentrations A decrease in GSH can result from reduced synthesis, oxidation, conjugation, protein S-glutathionylation, export, degradation, or loss of cellular integrity
Questions to Ask Your Healthcare Provider Could my symptoms be related to medication intolerance, dehydration, low intake, constipation, or another condition
According to Areti et al